ICD-10 Code B87.3 | Nasopharyngeal myiasis Symptoms, Diagnosis, Billing

Nasopharyngeal myiasis is a parasitic infestation of the nasopharynx by fly larvae, commonly associated with poor hygiene and certain environmental conditions. This condition can lead to significant morbidity, including nasal obstruction, pain, and secondary infections. Accurate coding with ICD-10 Code B87.3 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.

What is ICD-10 Code B87.3 for Nasopharyngeal myiasis?

ICD-10 Code B87.3 specifically represents nasopharyngeal myiasis, a condition characterized by the presence of fly larvae in the nasopharyngeal region. This code should be used when documenting cases of myiasis that affect the nasopharynx, particularly in patients presenting with symptoms such as nasal obstruction, discharge, or pain. Proper use of this code in clinical documentation and billing is crucial for accurate patient care and reimbursement.

ICD-10 Code B87.3 – Clinical Definition and Explanation of Nasopharyngeal myiasis

Nasopharyngeal myiasis is caused by the infestation of the nasopharynx by larvae of certain fly species, often due to exposure to contaminated environments or poor hygiene. The condition can progress rapidly, leading to complications such as secondary infections and significant discomfort, necessitating prompt medical attention.

Key Clinical Features:

• Presence of larvae in the nasopharynx
• Nasal obstruction and discharge
• Pain or discomfort in the nasal area
• Possible secondary bacterial infections

ICD-10 Code B87.3 for Nasopharyngeal myiasis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B87.3 is utilized to document the diagnosis of nasopharyngeal myiasis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B87.3 for Nasopharyngeal myiasis Mean in SOAP Notes?

ICD-10 Code B87.3 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of nasopharyngeal myiasis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B87.3 – Nasopharyngeal myiasis

Nasopharyngeal myiasis requires prompt medical intervention to prevent complications. Hospitalization may be necessary for severe cases, and treatment typically involves the removal of larvae and supportive care.

Antibiotic Therapy:

• First-line: Ivermectin (single dose)
• Alternative: Albendazole (if indicated)
• Duration: As per clinical judgment based on severity
• Consideration of secondary bacterial infections may require additional antibiotics.

Supportive Care:

• Symptomatic relief with analgesics
• Nasal saline irrigation to clear discharge
• Monitoring for signs of secondary infection
• Patient education on hygiene practices to prevent recurrence.

Infection Control:

• Implement standard precautions during treatment
• Educate patients on hygiene to prevent spread
• Monitor for outbreaks in endemic areas
• Report cases to public health authorities as necessary.

How to Document Symptoms of Nasopharyngeal myiasis (ICD-10 B87.3) in SOAP Notes

Subjective:

• Patient reports nasal obstruction and discomfort
• History of exposure to contaminated environments
• Complaints of nasal discharge with a foul odor
• No previous history of similar symptoms.

Objective:

• Visual inspection reveals larvae in the nasopharynx
• Nasal examination shows erythema and edema
• Vital signs stable; no fever noted
• Possible purulent discharge observed.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Nasopharyngeal myiasis (ICD-10 Code B87.3)

Assessment:

• Diagnosis: Nasopharyngeal myiasis, moderate severity
• ICD-10 Code: B87.3
• Contributing factors: Poor hygiene, exposure to contaminated environments
• Consideration of secondary infections.

Plan:

• Pharmacologic treatment: Ivermectin as first-line therapy
• Patient education on hygiene and prevention
• Monitoring for symptom resolution and potential complications
• Follow-up appointment in one week to reassess.

Treatment & Plan Section for ICD-10 Code B87.3 – Nasopharyngeal myiasis

• First-line treatment with Ivermectin or Albendazole as indicated
• Education on hygiene practices to prevent recurrence
• Monitoring for secondary infections and symptom resolution
• Follow-up care to ensure complete recovery.

Using ICD-10 Code B87.3 for Nasopharyngeal myiasis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings
• Document symptoms clearly in Subjective (S) and Objective (O) sections
• Ensure treatment plans align with clinical guidelines for justified billing
• Include relevant CPT codes for services rendered.

Related ICD-10 Codes Often Used with Nasopharyngeal myiasis

• B87.0 – Cutaneous myiasis
• B87.1 – Ocular myiasis
• B87.2 – Intestinal myiasis
• B87.9 – Myiasis, unspecified

ICD-10 Code B87.3 in Medical Billing and Insurance for Nasopharyngeal myiasis

ICD-10 Code B87.3 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.

Billing Notes:

• Document all relevant symptoms and findings to support the diagnosis
• Use the code in conjunction with appropriate CPT codes for services provided
• Ensure compliance with payer requirements for documentation
• Review coding guidelines to avoid denials.

Common CPT Pairings: